Product logins

Find logins to all Clarivate products below.


Aesthetic Injectables | Market Insights | Europe (Supplemental) | 2025

The European aesthetic injectable market is poised for expansion. Innovations and unique product offerings from key market players are expected to drive growth, while the entry of Asian manufacturers with cost-effective solutions could broaden access and affordability. Additionally, increasing acceptance and awareness of aesthetic procedures, along with a diversifying patient demographic, are anticipated to further fuel the demand for these treatments.

This Medtech 360 Report provides high-level market metrics for aesthetic injectables in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2033.

Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Large-Joint Reconstructive Implants – Market Insights – Europe
The European large-joint reconstructive implant market is poised for long-term sustained growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants,…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…